Attana’s QCM technology contributes to enhancement of cancer diagnosis through lectin-cancer tissues interaction
Cancer is one of the major health threats all over the world leading to high death mortality rates with approximately 10 million deaths in 2020 (WHO). Early diagnosis of malignant diseases including cancer is considered one of the most effective tools to decrease the cancer burden and reduce the treatment costs. Finding novel selective diagnostic agents that could target and differentially distinguish the cancer cells would improve the cancer diagnosis and treatment. Lectins are carbohydrate binding proteins commonly found in diverse sources in nature such as plants, bacteria, animals,